These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7803357)

  • 1. Comparison of the expression of interferon gamma, IL2, IL4, and lymphotoxin mRNA in experimental autoimmune uveoretinitis.
    Charteris DG; Lightman SL
    Br J Ophthalmol; 1994 Oct; 78(10):786-90. PubMed ID: 7803357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo lymphokine production in experimental autoimmune uveoretinitis.
    Charteris DG; Lightman SL
    Immunology; 1993 Mar; 78(3):387-92. PubMed ID: 8478022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma (IFN-gamma) production in vivo in experimental autoimmune uveoretinitis.
    Charteris DG; Lightman SL
    Immunology; 1992 Mar; 75(3):463-7. PubMed ID: 1572694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
    Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J
    J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uveitogenic T lymphocytes in the rat: pathogenicity vs. lymphokine production, adhesion molecules and surface antigen expression.
    Savion S; Oddo S; Grover S; Caspi RR
    J Neuroimmunol; 1994 Nov; 55(1):35-44. PubMed ID: 7525641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of retinal lymphocytes in experimental autoimmune uveoretinitis: phenotypic and functional characterization.
    Barton K; Calder VL; Lightman S
    Immunology; 1993 Mar; 78(3):393-8. PubMed ID: 8097489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte and experimental autoimmune uveoretinitis.
    Mochizuki M
    Jpn J Ophthalmol; 1987; 31(2):230-4. PubMed ID: 3312733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
    Xu H; Rizzo LV; Silver PB; Caspi RR
    Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental autoimmune uveitis and retinitis induced by S-antigen immunization].
    Misiuk-Hojło M; Ruiz-Moreno J; Thillaye B; de Kozak Y
    Klin Oczna; 1993; 95(3-4):101-4. PubMed ID: 8377430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis.
    Rajendram R; Saraswathy S; Rao NA
    Br J Ophthalmol; 2007 Apr; 91(4):531-7. PubMed ID: 17035279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of leflunomide on experimental autoimmune uveitis in Lewis rats].
    Fang C; Zhou D; Zhan S; He Y; Lin Z; Huang C; Li J
    Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):754-61. PubMed ID: 26693771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of experimental autoimmune uveoretinitis in Lewis rats with purified recombinant human retinal S-antigen fusion protein.
    Roberts AJ; Kasp E; Stanford M; Dumonde DC; Banga JP
    Eur J Immunol; 1992 Apr; 22(4):951-6. PubMed ID: 1551407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Ia antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis.
    Chan CC; Hooks JJ; Nussenblatt RB; Detrick B
    Curr Eye Res; 1986 Apr; 5(4):325-30. PubMed ID: 3486745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular injection of retinal S antigen: suppression of autoimmune uveitis.
    Mizuno K; Clark AF; Streilein JW
    Invest Ophthalmol Vis Sci; 1989 Apr; 30(4):772-4. PubMed ID: 2784789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphometric analysis of T lymphocyte compartmentation in experimental autoimmune uveoretinitis.
    Brown EC; Kasp E; Dumonde DC
    Clin Exp Immunol; 1989 Sep; 77(3):422-7. PubMed ID: 2805411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis.
    Yotsukura J; Huang H; Singh AK; Shichi H
    Cell Immunol; 1997 Dec; 182(2):89-98. PubMed ID: 9514702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis.
    Camelo S; Lajavardi L; Bochot A; Goldenberg B; Naud MC; Brunel N; Lescure B; Klein C; Fattal E; Behar-Cohen F; de Kozak Y
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):9-21. PubMed ID: 19232006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism.
    Hoey S; Grabowski PS; Ralston SH; Forrester JV; Liversidge J
    J Immunol; 1997 Nov; 159(10):5132-42. PubMed ID: 9366443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.